Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...
8h
Techno-Science.net on MSNA new light therapy to defeat one of the deadliest cancers 💡Ovarian cancer is particularly dangerous due to the high risk of metastasis. Researchers have developed a molecule capable, ...
11h
News Medical on MSNIgE antibodies show promise in targeting HER2 cancers resistant to other therapiesAntibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly being investigated as an alternative for chemotherapy and radiotherapy.
Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer InstituteSecondVersamune®platform candidate ...
Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” Oftentimes, her office will teach the patient how to inject it the first time, ...
The patient’s own doctors couldn’t agree on a cause. One said asthma. Another implicated her age, then 71. A third blamed ...
The number of new federal lawsuits fell 14% in the 2024 fiscal year as a result of a decline in mass tort litigation driven ...
Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...
As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results